J
Jörg Glahn
Researcher at Ruhr University Bochum
Publications - 16
Citations - 972
Jörg Glahn is an academic researcher from Ruhr University Bochum. The author has contributed to research in topics: Dysphagia & Swallowing. The author has an hindex of 11, co-authored 15 publications receiving 654 citations.
Papers
More filters
Journal ArticleDOI
Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.
Joji B. Kuramatsu,Stefan T. Gerner,Peter D. Schellinger,Jörg Glahn,Matthias Endres,Jan Sobesky,Julia Flechsenhar,Hermann Neugebauer,Hermann Neugebauer,Eric Jüttler,Eric Jüttler,Armin J. Grau,Frederick Palm,Joachim Röther,Peter Michels,Gerhard F. Hamann,Joachim Hüwel,Georg Hagemann,Beatrice Barber,Christoph Terborg,Frank Trostdorf,Hansjörg Bäzner,Aletta Roth,Johannes C. Wöhrle,Moritz Keller,Michael P. Schwarz,Gernot Reimann,Jens Volkmann,Wolfgang Müllges,Peter Kraft,Joseph Classen,Carsten Hobohm,Markus Horn,Angelika Milewski,Heinz Reichmann,Hauke Schneider,Eik Schimmel,Gereon R. Fink,Christian Dohmen,Henning Stetefeld,Otto W. Witte,Albrecht Günther,Tobias Neumann-Haefelin,Andras E. Racs,Martin Nueckel,Frank Erbguth,Stephan P. Kloska,Arnd Dörfler,Martin Köhrmann,Stefan Schwab,Hagen B. Huttner +50 more
TL;DR: Among patients with OAC-associated ICH, reversal of anticoagulation reversal and blood pressure (BP) with hematoma enlargement and resumption of OAC therapy was associated with lower risk of ischemic events, and these findings require replication and assessment in prospective studies.
Journal ArticleDOI
Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage
Joji B. Kuramatsu,Alessandro Biffi,Stefan T. Gerner,Jochen A. Sembill,Maximilian I. Sprügel,Audrey C Leasure,Lauren H Sansing,Charles C. Matouk,Guido J. Falcone,Matthias Endres,Karl Georg Haeusler,Karl Georg Haeusler,Jan Sobesky,Johannes Schurig,Sarah Zweynert,Miriam Bauer,Peter Vajkoczy,Peter A. Ringleb,Jan C. Purrucker,Timolaos Rizos,Jens Volkmann,Wolfgang Müllges,Peter Kraft,Anna-Lena Schubert,Frank Erbguth,Martin Nueckel,Peter D. Schellinger,Jörg Glahn,Ulrich J. Knappe,Gereon R. Fink,Christian Dohmen,Henning Stetefeld,Anna Lena Fisse,Jens Minnerup,Georg Hagemann,Florian Rakers,Heinz Reichmann,Hauke Schneider,Jan Rahmig,Albert C. Ludolph,Sebastian Stösser,Hermann Neugebauer,Hermann Neugebauer,Joachim Röther,Peter Michels,Michael P. Schwarz,Gernot Reimann,Hansjörg Bäzner,Henning Schwert,J Claßen,Dominik Michalski,Armin J. Grau,Frederick Palm,Christian Urbanek,Johannes C. Wöhrle,Fahid Alshammari,Markus Horn,Dirk Bahner,Otto W. Witte,Albrecht Günther,Gerhard F. Hamann,Manuel Hagen,Sebastian S. Roeder,Hannes Lücking,Arnd Dörfler,Fernando D. Testai,Daniel Woo,Stefan Schwab,Kevin N. Sheth,Hagen B. Huttner +69 more
TL;DR: Surgical hematoma evacuation, compared with conservative treatment, was not associated with improved functional outcome among patients with cerebellar ICH, and investigation is necessary to establish whether there are differing associations based on hematomas volume.
Journal ArticleDOI
Safety and clinical impact of FEES – results of the FEES-registry
Rainer Dziewas,Matthias auf dem Brinke,Ulrich Birkmann,Götz Bräuer,Kolja Busch,Franziska Cerra,Renate Damm-Lunau,Juliane Dunkel,Amelie Fellgiebel,Elisabeth Garms,Jörg Glahn,Sandra Hagen,Sophie Held,Christine Helfer,Mirko Hiller,Christina Horn-Schenk,Christoph Kley,Nikolaus Lange,Sriramya Lapa,Christian Ledl,Beate Lindner-Pfleghar,M. Mertl-Rötzer,Madeleine Müller,Hermann Neugebauer,Duygu Özsucu,Michael Ohms,Markus Perniß,Waltraud Pfeilschifter,Tanja Plass,Christian L. Roth,Robin Roukens,Tobias Schmidt-Wilcke,Beate Schumann,Julia Schwarze,Kathi Schweikert,Holger Stege,Dirk Theuerkauf,R. Thomas,Ulrich Vahle,Nancy Voigt,Hermann Weber,Cornelius J. Werner,Rainer Wirth,Ingo Wittich,Hartwig Woldag,Tobias Warnecke +45 more
TL;DR: This study confirmed that FEES, even when performed by less experienced clinicians is a safe and well tolerated procedure and significantly impacts on the patients’ clinical course.
Journal ArticleDOI
European Stroke Organisation and European Society for Swallowing Disorders guideline for the diagnosis and treatment of post-stroke dysphagia
Rainer Dziewas,Emilia Michou,Emilia Michou,Michaela Trapl-Grundschober,Avtar Lal,Ethem Murat Arsava,Philip M.W. Bath,Pere Clavé,Jörg Glahn,Shaheen Hamdy,Sue Pownall,Antonio Schindler,Margaret Walshe,Rainer Wirth,David Wright,Eric Verin +15 more
TL;DR: In this article, the authors developed guidelines to assist all members of the multidisciplinary team in their management of patients with post-stroke dysphagia (PSD), which increases the risk of complications, in particular aspiration pneumonia, malnutrition and dehydration.
Journal ArticleDOI
Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves.
Joji B. Kuramatsu,Jochen A. Sembill,Stefan T. Gerner,Maximilian I. Sprügel,Manuel Hagen,Sebastian S. Roeder,Matthias Endres,Karl Georg Haeusler,Karl Georg Haeusler,Jan Sobesky,Jan Sobesky,Johannes Schurig,Sarah Zweynert,Miriam Bauer,Peter Vajkoczy,Peter A. Ringleb,Jan C. Purrucker,Timolaos Rizos,Jens Volkmann,Wolfgang Müllges,Peter Kraft,Anna-Lena Schubert,Frank Erbguth,Martin Nueckel,Peter D. Schellinger,Jörg Glahn,Ulrich J. Knappe,Gereon R. Fink,Christian Dohmen,Henning Stetefeld,Anna Lena Fisse,Jens Minnerup,Georg Hagemann,Florian Rakers,Heinz Reichmann,Hauke Schneider,Sigrid Wöpking,Albert C. Ludolph,Sebastian Stösser,Hermann Neugebauer,Joachim Röther,Peter Michels,Michael P. Schwarz,Gernot Reimann,Hansjörg Bäzner,Henning Schwert,J Claßen,Dominik Michalski,Armin J. Grau,Frederick Palm,Christian Urbanek,Johannes C. Wöhrle,Fahid Alshammari,Markus Horn,Dirk Bahner,Otto W. Witte,Albrecht Günther,Gerhard F. Hamann,Hannes Lücking,Arnd Dörfler,Stephan Achenbach,Stefan Schwab,Hagen B. Huttner +62 more
TL;DR: Restarting TA within less than 2 weeks after ICH in patients with MHV was associated with increased haemorrhagic complications, andOptimal weighing—between least risks for thromboembolic and haemorsized complications—provided an earliest starting point of TA at Day 6, reserved only for patients at high throm boembolic risk.